PROOF OF PRINCIPLE

For a single client, closed multiple partnerships with
18 companies including Merck, Schering-Plough and Amgen

Assisted clients to reposition themselves to improve sales

Played key roles in taking 5 therapeutics to market

Developed IP strategy to allow client a license-free development program in the monoclonal antibody space

Developed and executed 3 year strategy to take early company to acquisition phase

Developed screening strategies for small molecule development

Developed grant strategies that have raised over $80 million

Retooled VC presentation and provided media training for a meeting which resulted in private financing


home | services | clients | our dna | news | contact us

Copyright © DNA Gateway International 2008. All Rights Reserved. Privacy Policy